Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford, Oxford University Hospitals NHS Foundation Trust and the Patient experience healthcare company Oneview Healthcare signed a research and development (R&D) agreement for clinical pathways, following the success of a Prostate Cancer Pathway pilot.

Image courtesy of Medical Sciences Division and John Cairns

Oneview Healthcare PLC (Oneview) have announced a partnership with The Chancellor Masters and Scholars of the University of Oxford and Oxford University Hospitals NHS Foundation Trust (OUH) to continue research and development on a clinical pathways product. The solution will ease administrative burden, digitise currently paper-based processes and ultimately expedite wait times and access to care.

In conjunction with a leading engineering company, University of Oxford, OUH and Oneview entered into a partnership in an agreement dated 31 January 2017 to pilot a digital pathways for prostate cancer to improve patient outcomes and deliver cost efficiencies to health systems. That pilot’s success is the catalyst for the new agreement. The prostate cancer pilot succeeded in the areas of clinical staff uptake, meeting or exceeding wait time goals, and providing an easy-to-use interface the clinicians embraced. The new research and development will focus on expanding the technology to include full commercial deployment at Oxford via a SMART on FHIR1 integration and expansion of scope to other types of  cancer (beyond prostate cancer). The partners expect to commercialise the new products globally, helping healthcare organisations around the world to digitise care pathways, connecting information across systems to drive clinical transformation and reduce variation.

Professor Freddie Hamdy, Head of Oxford University's Nuffield Department of Surgical Sciences and Divisional Director of Surgery and Oncology at OUH, commented: 'This is one of the most innovative projects Oxford have done in the past few years.'

James Fitter, CEO of Oneview Healthcare stated: 'This has been a textbook case of agile development with our team working side-by-side with the Oxford clinicians to solve real-world problems. Combining Oxford’s clinical expertise with our software innovation and integration skills has proved a powerful combination. We are delighted with the results of the pilot and the opportunity to move forward in developing other life-changing cancer pathways. We take pride in our partnership with Oxford University and OUH, and are honoured that we can all work together to advance technology that has so much potential to changes lives around the world.'

1 SMART on FHIR is an open standards-based platform for medical apps designed to promote interoperability

Press release courtsey of Oneview.

Similar stories

Clare Verrill receives Turing Fellowship

Thirty-three University of Oxford researchers have been named Turing Fellows for the 2021/22 academic year, including Associate Professor Clare Verrill from the Nuffield Department of Surgical Sciences (NDS).

Researchers awarded Wellcome Innovator Grant to investigate role of brainstem nucleus in human consciousness

Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.

Discovered gene patterns can predict prostate cancer treatment response

Nearly 40,000 men are diagnosed with prostate cancer each year in the UK. Perhaps the most significant clinical challenge today is deciding which type of treatment will work best for different patient groups.

Regent Lee wins top UKRI Future Leaders Fellowship

Dr Regent Lee of the Nuffield Department of Surgical Sciences is one of eight Oxford University academics who have been awarded significant financial funding from the UK Research and Innovation’s (UKRI) Future Leaders Fellowships Scheme.

Largest trial of carotid artery surgery and stenting finds similar long-term effects on stroke risk

Results from a major clinical trial demonstrate that both stenting and surgery are low-risk and similarly effective procedures for treating carotid artery disease.

Blog posts

Celebrating Anti-Bullying Week with words of kindness

Keeva Heap, who is undertaking a communications work experience placement at the Nuffield Department of Surgical Sciences (NDS), shares our words of kindness In honour of Anti-Bullying Week.

My virtual work experience with NDS and NDORMS

Louise Tan, a Year 12 student from Ballyclare in County Antrim, Northern Ireland, recently attended the joint NDS and NDORMS Virtual Work Experience. In this guest blog, Louise reflects on her experience.

Celebrating women of NDS

To celebrate 100 years since women were admitted as full members of the University and on the occasion of International Women's Day, a group of inspirational women in the Nuffield Department of Surgical Sciences (NDS) reflect on their journeys, their place in Medical Sciences and their vision for the next 100 years.

The life of a research nurse: supporting the Oxford COVID-19 Vaccine Trial

Research nurses in the NHS are playing a crucial role in helping to trial new coronavirus treatments and vaccines. Three NDS research nurses stepped up to help with the fight against this new disease. Here Bhumika Patel shares her experience of working on the Oxford COVID-19 Vaccine Trial.

Why I became a Peer Supporter

The Peer Support Programme was developed in recognition of the essential role students play in supporting and encouraging one another on a day-to-day basis throughout their time at university. NDS’ own Helen Stark discusses her experience of becoming a Peer Supporter.